Use of gelsolin to diagnose and treat inflammatory diseases
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsThomas P. Stossel, Teresia Anna Charlotta Magnuson Osborn, Andrej Tarkowski
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of gelsolin to treat inflammatory diseases (e.g., rheumatoid arthritis) and to the use of gelsolin to diagnose, monitor, and evaluate therapies of inflammatory diseases (e.g., rheumatoid arthritis).
Claims57
A method for characterizing a subject's risk profile of developing a future inflammatory disease, comprising:
- obtaining a level of gelsolin in the subject,
- comparing the level of the gelsolin to a predetermined value, and
- characterizing the subject's risk profile of developing an inflammatory disease based upon the level of gelsolin in comparison to the predetermined value, wherein a level of gelsolin at or below the predetermined level is indicative that the subject is at an elevated risk of developing the inflammatory disease, and wherein a level of gelsolin at or above the predetermined level is indicative that the subject is not at an elevated risk of developing the inflammatory disease.
A method for characterizing a subject's risk profile of developing a future inflammatory disease, comprising:
- obtaining a level of gelsolin in the subject,
- comparing the level of the gelsolin to a first predetermined value to establish a first risk value,
- obtaining a level of a second marker of inflammation in the subject,
- comparing the level of the second marker of inflammation to a second predetermined value to establish a second risk value, and
- characterizing the subject's risk profile of developing the inflammatory disease based upon the combination of the first risk value and the second risk value, wherein the combination of the first risk value and second risk value establishes a third risk value different from said first and second risk values.
A method for treating a subject having or at risk of developing an inflammatory disease comprising:
- administering an effective amount of gelsolin to a subject in need of such a treatment to treat the subject.
A method for treating a subject having or at risk of developing an inflammatory disease comprising:
- administering an effective amount of gelsolin to a subject in need of such a treatment to raise the level of gelsolin in the subject above a predetermined value.
A method for treating a subject to reduce the risk of an inflammatory disease comprising
- selecting a subject on the basis that the subject is known to have a below-normal level of gelsolin and
- administering gelsolin to the subject and/or a second agent in an effective amount to reduce the risk of the subject developing the inflammatory disease.
A method for treating a subject to reduce the risk of an inflammatory disease comprising
- selecting a subject on the basis that the subject is known to have a below-normal level of gelsolin and
- administering gelsolin to the subject and/or a second agent in an effective amount to raise the level of gelsolin in the subject above a predetermined value.
A method for treating a subject with a below-normal level of gelsolin comprising:
- (i) treating the subject with a first therapy for treating or reducing the risk of an inflammatory disease,
- (ii) obtaining a level of gelsolin in the subject,
- (iii) comparing the level of gelsolin obtained in (ii) to a predetermined value corresponding to a predetermined level of gelsolin, and if the predetermined level of gelsolin is not reached,
- (iv) treating the subject with a second agent for treating or reducing the risk of the inflammatory disease, and repeating (ii) and (iii) until the predetermined level of gelsolin is reached.
A method for evaluating the efficacy of a therapy for treating or reducing the risk of an inflammatory disease in a subject comprising:
- (i) obtaining a level of gelsolin in a subject undergoing therapy with an agent to treat or reduce the risk of an inflammatory disease,
- (ii) comparing the level of gelsolin obtained in (i) to a predetermined value corresponding to a level of gelsolin in an apparently healthy control population, and
- (iii) determining whether the level of gelsolin in (i) is at or above the predetermined level, said determination being indicative of whether the therapy is efficacious.
A method for deciding on the course of a therapy in a subject, comprising:
- (i) obtaining a level of gelsolin in a subject undergoing a therapy to treat or reduce the risk of an inflammatory disease,
- (ii) comparing the level of gelsolin obtained in (i) to a predetermined value corresponding to a level of gelsolin,
- (iii) determining whether the level of gelsolin obtained in (i) is at or below the predetermined level, and
- (iv) deciding on the course of the therapy based on such determination.
Dependencies are inferred from the claim text.